Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The nonapeptide, composed of nine amino acids, was named for its initial observation of delta EEG wave induction in research subjects, an electrophysiological pattern associated with deep sleep stages
The published research literature has investigated: GHRH receptor activation in pituitary somatotroph cells Pulsatile release of endogenous growth hormone Subsequent IGF-1 elevation through downstream GH signaling Maintained natural feedback regulation through somatostatin and IGF-1 DPP-4-resistant pharmacokinetics from the trans-3-hexenoic acid modification The two compounds produce fundamentally different research effects: AOD-9604 produces lipolytic activity without affecting IGF-1 or broader GH-mediated signaling Tesamorelin produces full GH axis activation including IGF-1 elevation and broader GH-mediated effects Pharmacokinetic Comparison The compounds have different pharmacokinetic profiles: AOD-9604
doi:10.1159/000505363
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinsons disease pathogenesis
Stratification of astrocytes in healthy and diseased brain
